|
Volumn 99, Issue 3, 2013, Pages
|
Lapatinib and renal impairment: A case report
|
Author keywords
Hemodialysis; Human epidermal growth factor receptor 2; Lapatinib; Letrozole; Metastatic breast cancer
|
Indexed keywords
ANASTROZOLE;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ESTROGEN RECEPTOR;
GOSERELIN;
KI 67 ANTIGEN;
LAPATINIB;
LETROZOLE;
PROGESTERONE RECEPTOR;
TAMOXIFEN;
TRASTUZUMAB;
ANTINEOPLASTIC AGENT;
ERBB2 PROTEIN, HUMAN;
MONOCLONAL ANTIBODY;
NITRILE;
QUINAZOLINE DERIVATIVE;
TRIAZOLE DERIVATIVE;
TUMOR MARKER;
ABSENCE OF SIDE EFFECTS;
ADULT;
ARTICLE;
BREAST CANCER;
BREAST CARCINOMA;
CANCER ADJUVANT THERAPY;
CANCER HORMONE THERAPY;
CASE REPORT;
DISEASE COURSE;
DRUG TREATMENT FAILURE;
FEMALE;
HEMODIALYSIS;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
LIVER BIOPSY;
LIVER METASTASIS;
LYMPH NODE DISSECTION;
MASTECTOMY;
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS;
MIDDLE AGED;
OLIGO METASTATIC TRIPLE POSITIVE BREAST CANCER;
POSTMENOPAUSE;
BREAST TUMOR;
CARCINOMA, DUCTAL, BREAST;
CHEMISTRY;
COMPLICATION;
DRUG ADMINISTRATION;
ECHOGRAPHY;
GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE;
LIVER NEOPLASMS;
PATHOLOGY;
RENAL REPLACEMENT THERAPY;
SECONDARY;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CARCINOMA, DUCTAL, BREAST;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE;
HUMANS;
LIVER NEOPLASMS;
MIDDLE AGED;
NITRILES;
POSTMENOPAUSE;
QUINAZOLINES;
RECEPTOR, ERBB-2;
RECEPTORS, ESTROGEN;
RENAL DIALYSIS;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TRIAZOLES;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 84885995645
PISSN: 03008916
EISSN: 20382529
Source Type: Journal
DOI: 10.1177/030089161309900334 Document Type: Article |
Times cited : (10)
|
References (3)
|